Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Gene |
RCV000417977 | SCV000521501 | likely pathogenic | not provided | 2017-06-09 | criteria provided, single submitter | clinical testing | The G2724W variant in the BRCA2 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. This variant was not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The G2724W variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution is conserved across species, and occurs within the DNA binding domain and DSS1 contacting residue (Yang et al., 2002). In silico analysis predicts this variant is probably damaging to the protein structure/function. Based on currently available evidence, we consider G2724W to be a likely pathogenic variant. |